Post by
EbbFlow88 on Jan 03, 2023 4:07pm
Something to think about...
Something I can't stop thinking about is that the current market cap is around $585M assuming 112.5M shares outstanding at the current price.
Biotoscana was purchased for $369M CAD and Exelon was purchased for $217M CAD. Neither of which was purchased at a high multiple. Total purchases of those two assets = $586M
Excluding the recent debt deal, substract cash + equivalents and financial assets from Mcap and you get ~290M CAD for GBT and drugs.
585 - 145 - 150 = 290M
So, at today's price, buyers are getting those assets at $0.50 on the dollar for what was paid, which our frugal management team deemed worth the purchase.
Also, ~45M in cash from Ops is a return on that 290M of 15.5%
Either they way overpaid for those assets (as chianchin most definitely believes) or this is an unbelievable gift from the market. My money is on the latter.
Comment by
MrMugsy on Jan 10, 2023 3:46pm
Some kind of deal - even if it's small would seem logical in 2023. I know a small pharma that's getting regular requests to tie up for their heavy bank account and that's only $42 MM. Thinking, GUD should be able to work this environment to their favor and pick up some assets. Let's see.
Comment by
Chianchin on Jan 10, 2023 5:07pm
Yep making money on people who are making $2 dollars a day and fighting for $5, are you dumb, deaft, blind and callus to the human tragedies takiing place in LATAM? Hundreds of people died in Peru yesterday, of 1500 people arested in Brazilia and scores injured just for starter. What a mouth piece of fermented sht
Comment by
EbbFlow88 on Jan 10, 2023 5:42pm
That was timely! So they repurchased another 450k shares in December.
Comment by
Chianchin on Jan 10, 2023 6:18pm
..and to be able do that they borrowed 32 millions dollars of worthless of monopolyLatam money paper depretiating @ 10% per months. When they can no loger borrow soon the share price will sink to $ 2 or less. Are you that inepth mugys boy alias.?